Texas commits $100 million to legalize Ibogaine as addiction cure

The $100 Million Texas Moonshot

In a historic legislative shift,

has officially committed $100 million to fund the development of

through the

drug approval process. This initiative represents the largest single investment in psychedelic research in history, aimed specifically at addressing the devastating impact of opioid addiction and traumatic brain injury (TBI) within the state and the broader

.

W. Bryan Hubbard

, CEO of

Americans for Ibogaine

, confirmed that the funding was secured after a blistering five-and-a-half-month campaign to educate and persuade 188 Texas legislators. The bill received near-unanimous support, passing with 181 out of 188 votes across the

Texas House of Representatives

and the

.

The political maneuver required to unlock these funds involved high-stakes negotiations in the final hours of the budget cycle.

W. Bryan Hubbard

and former

Governor

worked directly with

and the

Texas House Speaker

to ensure the project remained a priority. This move signals a departure from traditional Republican "tough on crime" drug policies, moving instead toward a model of medical intervention and healing. The

initiative is designed as a sovereign effort, meaning the state will lead the drug development independently, without relying on private pharmaceutical partners, to ensure the medicine remains accessible and focused on public health rather than profit margins.

The Sophisticated Molecule from Gabon

Texas commits $100 million to legalize Ibogaine as addiction cure — Joe Rogan Experience #2477 - Rick Perry & W. Bryan Hubbard

is a powerful alkaloid derived from the

shrub, which is native to the

basin, specifically

. For centuries, the

spiritualists and indigenous tribes have used the plant in sacred rituals. Its modern medical utility was discovered in the 1960s when an individual addicted to heroin took the substance and experienced a complete interruption of withdrawal symptoms and cravings. This discovery touched off 60 years of field studies, though official

research was stymied by the

administration's

, which placed the compound in Schedule I.

The unique pharmacology of

acts as a "reset button" for the brain's dopamine system. Unlike traditional addiction treatments that require months of abstinence or the use of maintenance drugs like methadone,

appears to resolve physiological substance dependence in 48 to 72 hours.

W. Bryan Hubbard

explains that the molecule provides a profound interruption of compulsions, making it effective not just for opioids, but for alcohol, cocaine, methamphetamine, and even behavioral addictions like gambling. The treatment is intense, often described as a 12-to-16-hour state of semi-paralysis and physical purging, but it provides what

W. Bryan Hubbard

calls an "affirmation of individual human divinity."

Healing the Wounds of War

One of the most compelling arguments for the medicalization of

comes from the

U.S. Special Operations

community. Since 2018, high-level veterans—including

like

and

—have been traveling to

for treatment. These warfighters often return with symptoms of TBI, treatment-resistant depression, and suicidal ideation that the

Department of Veterans Affairs

system has failed to cure with synthetic pharmacology.

witnessed this crisis firsthand when

lived with him at the governor’s mansion for two years.

noted that while physical rehab helped manage symptoms, it was only

that finally cleared the opioid addiction and neurological fog. New research from

Stanford University

, led by

, has utilized functional MRIs to show that

has remarkable neuro-regenerative capacities. In study participants, brain scans that previously showed the "addicted look" of chronic opioid use returned to a normal, healthy state within 72 hours of a single dose. This rapid restoration of the prefrontal cortex—where focus, concentration, and emotional regulation reside—is unprecedented in Western medicine.

A Multi-State Coalition Against Federal Bureaucracy

The

victory has triggered a domino effect across the

.

Americans for Ibogaine

is now coordinating with legislators in 22 states to form a unified front.

has already passed its own

initiative, allocating $5 million from its opioid settlement funds to partner with

. Similar bills are advancing in

,

,

,

, and

. This "states-led" strategy is a deliberate attempt to bypass what

W. Bryan Hubbard

describes as a "corrupt and incompetent federal bureaucracy" that has favored pharmaceutical companies like

over effective cures.

W. Bryan Hubbard

points to the

as a primary obstacle, specifically their refusal to honor the "Right to Try" law signed in 2018. While the law allows patients with life-threatening conditions to access medications that have cleared Phase I safety trials, the

has arbitrarily asserted that this does not apply to Schedule I substances. By forming a multi-state coalition, these leaders intend to use political and economic leverage to force a rescheduling of

from Schedule I to Schedule II or III. They are also seeking sovereign partnerships with

Native American

tribes, such as the

, to establish legal treatment centers on tribal land, potentially providing immediate access while the federal battle continues.

Rick Perry’s Personal Transformation

Former

has become the most unlikely advocate for psychedelic medicine. A self-described "hard no" on drugs for 40 years,

admits that his perspective was shaped by the

era and the "Just Say No" campaign. However, his willingness to change his mind was sparked by his experience with criminal justice reform in the early 2000s, where he learned that rehabilitation was more effective than incarceration. He now refers to himself as the "Johnny Appleseed of Ibogaine."

To ensure the legitimacy of his advocacy,

underwent the

treatment himself in 2023. Although he did not have a substance abuse problem, he sought the treatment for the neuro-regenerative benefits to address three major concussions sustained in his youth.

shared that his post-treatment brain scans showed a 27% increase in activity in his prefrontal cortex. More strikingly,

, a neurosurgeon and former skeptic, told

that six months after the treatment, the mild atrophy in his brain had completely disappeared, making his brain look like that of a 40-year-old.

emphasizes that he is willing to risk his lifelong political reputation because the lives of veterans and addicts are worth more than any individual’s status.

The Spiritual Famine and the Future

Beyond the clinical data and political maneuvering,

W. Bryan Hubbard

views the

movement as an answer to a profound "spiritual famine" in America. He argues that modern power structures have monetized human misery, keeping people trapped in cycles of addiction and trauma.

, according to

W. Bryan Hubbard

, acts as a "divine emancipator" that allows individuals to reclaim their autonomy and recognize their inherent value. This perspective is gaining traction even in conservative religious circles, with upcoming books like

’s A Christian’s Guide to Psychedelics providing a scriptural framework for the use of these plants.

The long-term vision for

Americans for Ibogaine

is the full integration of the medicine into the

healthcare system within three years. This "moonshot" aims to replace ineffective, opioid-based maintenance programs with a single, redemptive treatment. With

leading the charge and

signing on as an official international partner, the momentum appears unstoppable. As

noted, the world is finally waking up to the idea that these maligned substances might hold the key to solving the most persistent crises of the modern age.

Texas commits $100 million to legalize Ibogaine as addiction cure

Fancy watching it?

Watch the full video and context

8 min read